ClinicalTrials.Veeva

Menu

Periocline as an Adjunct to Scaling and Root Planing for Adult Periodontitis

S

Sunstar

Status and phase

Completed
Phase 3

Conditions

Adult Periodontitis

Treatments

Drug: minocycline HCl 2.1%
Procedure: Scaling and root planing

Study type

Interventional

Funder types

Industry

Identifiers

NCT00529555
SB-PER-05-001

Details and patient eligibility

About

Periodontal disease (commonly called gum disease) is generally treated by deep cleaning of the root surfaces of the teeth. This is also called scaling and root planing. Placing a topical antibiotic into the periodontal pocket at the time of scaling and root planing may help reduce pocket depth and thus help the periodontal disease. Periocline (minocycline HCl) 2.1% gel is a topical antibiotic approved in a number of countries for this use, and is now being tested in the US.

Enrollment

602 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • moderate to severe periodontitis

Exclusion criteria

  • recent periodontal therapy
  • certain medical or dental conditions
  • pregnancy
  • allergy to active drug or related drugs

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

602 participants in 3 patient groups, including a placebo group

Scaling and root planing + SHAM TX
Sham Comparator group
Description:
sham treatment
Treatment:
Procedure: Scaling and root planing
Scaling and root planing + Vehicle
Placebo Comparator group
Description:
Placebo
Treatment:
Procedure: Scaling and root planing
Scaling & root planing + Periocline Gel
Active Comparator group
Description:
Minocycline HCL 2.1%
Treatment:
Drug: minocycline HCl 2.1%

Trial contacts and locations

10

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems